Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ: MRNA )

39.59 +0.20 (+0.51%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
99 100 Next >
Beware! 3 Nasdaq Stocks Waving Massive Red Flags Right Now.
A range of worries are pulling these Nasdaq stocks to sell lower and clouding the outlook for their share prices. 
Via InvestorPlace
3 Stocks to Avoid Like the Plague Right Now: MRNA, GPS, PTON
The good economic times of the past few years appear to be ending. As such, it's time to exit these three stocks to avoid. 
Via InvestorPlace
Check Out What Whales Are Doing With MRNA
Via Benzinga
Amazon, Moderna And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed slightly higher on Monday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
2 Stocks That Sank Hard on Monday
Investors were generally in wait-and-see mode, but not with certain individual stocks. 
Via The Motley Fool
Why Moderna Stock Is Sinking Today
Moderna, Inc. (NASDAQ: MRNA) shares are trading lower Monday alongside other vaccine stocks amid a selloff after the sector gained amid ri 
Via Benzinga
Here Are 15 New Reasons to Be Bullish About Moderna Stock
With its first big successes drawing to a close, new products are on the horizon. 
Via The Motley Fool
Moderna Unusual Options Activity For September 15
Via Benzinga
Is Moderna Stock a Top Buy?
Wall Street is bullish on the biotech's novel pipeline. 
Via The Motley Fool
Stocks Sluggish As Oil, Bond Yields Rise
Stocks are stagnant to kick off the week, with all three major indexes cautiously higher midday. 
Via Talk Markets
Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday
U.S. stocks traded mostly flat on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
2 Top Trends to Invest $500 In Right Now
Early investors in these trends may reap the rewards over time. 
Via The Motley Fool
Looking for Growth? These Companies' Revenue May Skyrocket
Catalysts on the horizon could drive gains in these top stocks. 
Via The Motley Fool
This 1 Number May Completely Change Your Opinion About Moderna
Moderna shares look dirt cheap considering the company's prospects. 
Via The Motley Fool
Moderna Inc. (NASDAQ: MRNA) Making Surprising Moves in Wednesday Session
Via Investor Brand Network
More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get... 
Via Benzinga
Exposures COVID-19 Product Safety
The 3 Most Undervalued Pharma Stocks to Buy in September 2023
Investing in pharmaceutical industry always carries risk, but several pharma stocks have an attractive risk/reward valuation right now. 
Via InvestorPlace
Why Moderna Stock Is Rising Today
Moderna, Inc. (NASDAQ: MRNA) shares are trading higher after the EMA Committee for Medicinal Products for Human Use adopted an opinion recommending authorization of the company's updated COVID-19 
Via Benzinga
Exposures COVID-19
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs
On Wednesday, Moderna Inc (NASDAQ: MRNA) conducted an R&D Day event outlining its strategic initiatives across four key areas - Respiratory Vaccines, Latent/Other Vaccines, Oncology Therapeutics,  
Via Benzinga
Exposures COVID-19
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union
Via ACCESSWIRE
Why COVID Vaccine Demand Might Not Be That Strong
COVID hospitalizations are rising, but they're nowhere near the levels they were at a year or two ago. 
Via The Motley Fool
Exposures COVID-19
The Labor Market In Australia Remains Resilient
After an unexpected drop in the number of jobs in Australia in July, there was an increase in August, and the unemployment rate remained unchanged, indicating that the labor market remains resilient. 
Via Talk Markets
The 7 Best Meme Stocks to Buy Now: September 2023
Consider these seven past and present faves of the Reddit set to be the best meme stocks to buy this month. 
Via InvestorPlace
Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm
Moderna released encouraging results for its late-stage trial of its flu vaccine. Now, MRNA stock is looking like more than a one-trick pony. 
Via InvestorPlace
Mainz Biomed Paves The Way For Early Colorectal Cancer Diagnosis And Even Prevention
By the words of Dr. Ruediger Dahlke, cancer is a caricature of today’s modern society as it reflects the dark side ‘growth’. Our civilization is clearly more on the dark side of growth with technology... 
Via Benzinga
Europe Set To Launch Anti-Subsidy Probe Into Chinese EVs, American Airlines and Spirit Lower Profit Outlook, Manchester United's New Shirt Sponsor: Today's Top Stories
Financial Times Europe Set To Launch Anti-Subsidy Probe Into Chinese Electric Vehicles 
Via Benzinga
Moderna, REV Group, Rocket Pharmaceuticals And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mixed, with the Dow Jones gaining around 10 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Moderna Stock Trading Higher Today?
Moderna Inc (NASDAQ: MRNA) announced its intentions to launch up to 15 new products and advance up to 50 mRNA medicines into clinical trials over the next five years. 
Via Benzinga
Say Goodbye to Free COVID-19 Shots: CDC Approves Priced Boosters for Omicron Subvariants
The Centers for Disease Control and Prevention (CDC) has officially endorsed COVID-19 booster shots for individuals six months and older as we approach the fall season. 
Via Benzinga
Exposures COVID-19
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.